NFJ Investment Group LLC Has $10.92 Million Holdings in Addus HomeCare Co. (NASDAQ:ADUS)

NFJ Investment Group LLC decreased its stake in Addus HomeCare Co. (NASDAQ:ADUS) by 34.9% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 82,106 shares of the company’s stock after selling 43,948 shares during the quarter. NFJ Investment Group LLC owned approximately 0.45% of Addus HomeCare worth $10,923,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. UMB Bank n.a. boosted its holdings in shares of Addus HomeCare by 64.2% in the 2nd quarter. UMB Bank n.a. now owns 225 shares of the company’s stock worth $26,000 after acquiring an additional 88 shares in the last quarter. Quest Partners LLC acquired a new position in Addus HomeCare in the second quarter worth $31,000. Innealta Capital LLC acquired a new stake in shares of Addus HomeCare in the second quarter valued at $44,000. Farther Finance Advisors LLC increased its stake in shares of Addus HomeCare by 9,150.0% in the third quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock valued at $49,000 after buying an additional 366 shares in the last quarter. Finally, Sandia Investment Management LP bought a new position in shares of Addus HomeCare in the second quarter worth about $58,000. 95.35% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several research firms have recently commented on ADUS. Oppenheimer increased their price target on shares of Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a research note on Monday, September 23rd. KeyCorp assumed coverage on Addus HomeCare in a research report on Friday, October 11th. They issued an “overweight” rating and a $150.00 price objective on the stock. Stephens boosted their target price on Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 6th. Macquarie reiterated an “outperform” rating and issued a $139.00 price target on shares of Addus HomeCare in a report on Monday, November 4th. Finally, Royal Bank of Canada reiterated an “outperform” rating and issued a $136.00 price objective on shares of Addus HomeCare in a research report on Thursday, November 14th. One equities research analyst has rated the stock with a sell rating, eight have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $131.63.

Insider Buying and Selling at Addus HomeCare

In other Addus HomeCare news, CEO R Dirk Allison sold 12,500 shares of the business’s stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $123.16, for a total value of $1,539,500.00. Following the sale, the chief executive officer now owns 141,897 shares in the company, valued at approximately $17,476,034.52. The trade was a 8.10 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Esteban Lopez sold 500 shares of the firm’s stock in a transaction that occurred on Wednesday, September 4th. The stock was sold at an average price of $130.03, for a total transaction of $65,015.00. Following the transaction, the director now directly owns 3,866 shares of the company’s stock, valued at $502,695.98. This represents a 11.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 13,500 shares of company stock valued at $1,668,265. 4.60% of the stock is currently owned by corporate insiders.

Addus HomeCare Stock Up 0.6 %

Shares of ADUS traded up $0.78 during trading hours on Tuesday, reaching $123.87. The stock had a trading volume of 2,409 shares, compared to its average volume of 131,263. The company has a market cap of $2.25 billion, a P/E ratio of 28.17, a P/E/G ratio of 2.15 and a beta of 1.02. Addus HomeCare Co. has a 52 week low of $85.94 and a 52 week high of $136.12. The firm has a 50-day moving average of $127.11 and a 200 day moving average of $123.84.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings results on Monday, November 4th. The company reported $1.30 EPS for the quarter, topping analysts’ consensus estimates of $1.28 by $0.02. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The company had revenue of $289.80 million for the quarter, compared to analyst estimates of $289.42 million. During the same quarter last year, the firm posted $1.03 earnings per share. Addus HomeCare’s revenue was up 7.1% compared to the same quarter last year. As a group, equities analysts expect that Addus HomeCare Co. will post 4.58 earnings per share for the current year.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.